ClinVar Miner

Submissions for variant NM_000026.4(ADSL):c.1276C>T (p.Arg426Cys)

gnomAD frequency: 0.00001  dbSNP: rs796052248
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000186692 SCV000240258 pathogenic not provided 2012-07-19 criteria provided, single submitter clinical testing p.Arg426Cys (CGT>TGT): c.1276 C>T in exon 12 of the ADSL gene (NM_000026.2) The Arg426Cys mutation is a non-conservative amino acid change, since a positively charged Arginine is replaced with a neutral Cysteine, which may also affect formation of disulfide bonds. Although this specific mutation has not been published previously to our knowledge, a different missense substitution at the same position, Arg426His, is the most commonly observed mutation in ADSL and has been reported in homozygous as well as compound heterozgous form (Jurecka et al., 2008; Marie et al., 1999; Zikanova et al. 2010). The Arg426His mutation is located at the surface of the substrate channel of the encoded protein where its presence disrupts arginine-mediated interactions with Gln409 and Asp422 residues. Functional studies have demonstrated that Arg426His significantly reduces enzyme activity and thermal stability (Zikanova et al. 2010). The variant is found in CHILD-EPI panel(s).
Clinical Genomics Program, Stanford Medicine RCV001253786 SCV001427090 uncertain significance Adenylosuccinate lyase deficiency 2019-10-18 no assertion criteria provided clinical testing The p.Arg426Cys variant in the ADSL gene has not been previously reported in association with disease. This variant was absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). Notably, a different amino acid change (p.Arg426His) has been previously reported at this residue. The p.Arg426His variant is classified as pathogenic and is the most commonly observed variant associated with adenylosuccinase deficiency (Jurecka et al., 2015), which suggests another change at this residue, such as p.Arg426Cys, may similarly disrupt protein function. Computational tools predict that this variant is deleterious; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, the significance of the p.Arg426Cys variant is uncertain. Additional information is needed to resolve the significance of this variant. [ACMG evidence codes used: PM2, PM5, PP3]

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.